Las Vegas, NV -- (SBWIRE) -- 01/17/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Newcastle Investment Corp.(NYSE:NCT), Allied Nevada Gold Corp.(NYSEMKT:ANV), Lloyds Banking Group PLC (ADR)(NYSE:LYG), CEL-SCI Corporation(NYSEMKT:CVM)
Newcastle Investment Corp.(NYSE:NCT) was a volume gainer of 4.55 million shares and the average volume of the stock remained 3.83 million shares. The stock opened the session at $5.87 and finished at the end of the day at $5.82 and the stock plunged -0.68%.The market capitalization of the stock remained 2.05 billion. Newcastle Investment Corp. operates as a real estate investment and finance company in the United States. Newcastle Investment Corp. was founded in 1998 and is based in New York, New York.
Has NCT Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Allied Nevada Gold Corp.(NYSEMKT:ANV) exchanged 4.22 million shares and the average volume remained 4.41 million shares. The stock closed the session at $4.80 with the gain of 4.35%. Allied Nevada Gold Corp., a gold and silver producer, focuses on the mining, development, and exploration of properties in Nevada. The company?s principal products include unrefined gold and silver bars.
Will ANV Continue To Move Higher? Find Out Here
Lloyds Banking Group PLC (ADR)(NYSE:LYG) decreased -2.43% and its closing price was $5.62. The volume of the stock was 4.38 million shares and the average volume remained 3.22 million shares. The market capitalization of the stock remained 100.39 billion. The beta of the stock remained 2.35. Lloyds Banking Group plc provides banking and financial services to personal, commercial, and corporate customers in the United Kingdom and internationally. The company operates in four divisions: Retail; Commercial Banking; Wealth, Asset Finance, and International; and Insurance.
Will LYG Get Buyers Even After The Recent Rally? Find Out Here
CEL-SCI Corporation(NYSEMKT:CVM) exchanged 4.21 million shares in the previous trading session, and its average trading remained 1.31 million shares. CVM dropped -3.7% and it closed the trading at $0.910. The market capitalization of the stock remained 44.45 million. CEL-SCI Corporation is engaged in the research and development of drugs and vaccines. The company?s lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer.
Has CVM Found The Bottom and Ready To Move Up? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)